SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis

Alexandre Chlenski, Shuqing Liu, Susan E. Crawford, Olga V. Volpert, George H. DeVries, Amy Evangelista, Qiwei Yang, Helen R. Salwen, Robert Farrer, James Bray, Susan L. Cohn

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

Neuroblastoma (NB), a common pediatric neoplasm, consists of two main cell populations: neuroblastic/ganglionic cells and Schwann cells. NB tumors with abundant Schwannian stroma display a more benign clinical behavior than stroma-poor tumors. Recent studies suggest that Schwann cells influence NB tumor growth via secreted factors that induce differentiation, suppress proliferation, and inhibit angiogenesis. Two angiogenesis inhibitors, pigment epithelium-derived factor and tissue inhibitor of metalloproteinase-2, have been detected in Schwann cell secretions. Here, we isolated another Schwann cell-derived secreted inhibitor of angiogenesis, a 43-kDa protein identified as SPARC (secreted protein acidic and rich in cysteine), an extracellular matrix protein. We found SPARC to be critical for the antiangiogenic phenotype of cultured Schwann cells. We also show that purified SPARC potently inhibits angiogenesis and significantly impairs NB tumor growth in vivo. SPARC may be an effective candidate for the treatment of children with clinically aggressive, Schwannian stroma-poor NB tumors.

Original languageEnglish (US)
Pages (from-to)7357-7363
Number of pages7
JournalCancer Research
Volume62
Issue number24
StatePublished - Dec 15 2002

Fingerprint

Neuroblastoma
Schwann Cells
Cysteine
Neoplasms
Proteins
Angiogenesis Inhibitors
Tissue Inhibitor of Metalloproteinase-2
Extracellular Matrix Proteins
Growth
Cultured Cells
Pediatrics
Phenotype
Population

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Chlenski, A., Liu, S., Crawford, S. E., Volpert, O. V., DeVries, G. H., Evangelista, A., ... Cohn, S. L. (2002). SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Research, 62(24), 7357-7363.

SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. / Chlenski, Alexandre; Liu, Shuqing; Crawford, Susan E.; Volpert, Olga V.; DeVries, George H.; Evangelista, Amy; Yang, Qiwei; Salwen, Helen R.; Farrer, Robert; Bray, James; Cohn, Susan L.

In: Cancer Research, Vol. 62, No. 24, 15.12.2002, p. 7357-7363.

Research output: Contribution to journalArticle

Chlenski, A, Liu, S, Crawford, SE, Volpert, OV, DeVries, GH, Evangelista, A, Yang, Q, Salwen, HR, Farrer, R, Bray, J & Cohn, SL 2002, 'SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis', Cancer Research, vol. 62, no. 24, pp. 7357-7363.
Chlenski A, Liu S, Crawford SE, Volpert OV, DeVries GH, Evangelista A et al. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Research. 2002 Dec 15;62(24):7357-7363.
Chlenski, Alexandre ; Liu, Shuqing ; Crawford, Susan E. ; Volpert, Olga V. ; DeVries, George H. ; Evangelista, Amy ; Yang, Qiwei ; Salwen, Helen R. ; Farrer, Robert ; Bray, James ; Cohn, Susan L. / SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. In: Cancer Research. 2002 ; Vol. 62, No. 24. pp. 7357-7363.
@article{4c533cf2941d471e86a35349682b1276,
title = "SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis",
abstract = "Neuroblastoma (NB), a common pediatric neoplasm, consists of two main cell populations: neuroblastic/ganglionic cells and Schwann cells. NB tumors with abundant Schwannian stroma display a more benign clinical behavior than stroma-poor tumors. Recent studies suggest that Schwann cells influence NB tumor growth via secreted factors that induce differentiation, suppress proliferation, and inhibit angiogenesis. Two angiogenesis inhibitors, pigment epithelium-derived factor and tissue inhibitor of metalloproteinase-2, have been detected in Schwann cell secretions. Here, we isolated another Schwann cell-derived secreted inhibitor of angiogenesis, a 43-kDa protein identified as SPARC (secreted protein acidic and rich in cysteine), an extracellular matrix protein. We found SPARC to be critical for the antiangiogenic phenotype of cultured Schwann cells. We also show that purified SPARC potently inhibits angiogenesis and significantly impairs NB tumor growth in vivo. SPARC may be an effective candidate for the treatment of children with clinically aggressive, Schwannian stroma-poor NB tumors.",
author = "Alexandre Chlenski and Shuqing Liu and Crawford, {Susan E.} and Volpert, {Olga V.} and DeVries, {George H.} and Amy Evangelista and Qiwei Yang and Salwen, {Helen R.} and Robert Farrer and James Bray and Cohn, {Susan L.}",
year = "2002",
month = "12",
day = "15",
language = "English (US)",
volume = "62",
pages = "7357--7363",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "24",

}

TY - JOUR

T1 - SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis

AU - Chlenski, Alexandre

AU - Liu, Shuqing

AU - Crawford, Susan E.

AU - Volpert, Olga V.

AU - DeVries, George H.

AU - Evangelista, Amy

AU - Yang, Qiwei

AU - Salwen, Helen R.

AU - Farrer, Robert

AU - Bray, James

AU - Cohn, Susan L.

PY - 2002/12/15

Y1 - 2002/12/15

N2 - Neuroblastoma (NB), a common pediatric neoplasm, consists of two main cell populations: neuroblastic/ganglionic cells and Schwann cells. NB tumors with abundant Schwannian stroma display a more benign clinical behavior than stroma-poor tumors. Recent studies suggest that Schwann cells influence NB tumor growth via secreted factors that induce differentiation, suppress proliferation, and inhibit angiogenesis. Two angiogenesis inhibitors, pigment epithelium-derived factor and tissue inhibitor of metalloproteinase-2, have been detected in Schwann cell secretions. Here, we isolated another Schwann cell-derived secreted inhibitor of angiogenesis, a 43-kDa protein identified as SPARC (secreted protein acidic and rich in cysteine), an extracellular matrix protein. We found SPARC to be critical for the antiangiogenic phenotype of cultured Schwann cells. We also show that purified SPARC potently inhibits angiogenesis and significantly impairs NB tumor growth in vivo. SPARC may be an effective candidate for the treatment of children with clinically aggressive, Schwannian stroma-poor NB tumors.

AB - Neuroblastoma (NB), a common pediatric neoplasm, consists of two main cell populations: neuroblastic/ganglionic cells and Schwann cells. NB tumors with abundant Schwannian stroma display a more benign clinical behavior than stroma-poor tumors. Recent studies suggest that Schwann cells influence NB tumor growth via secreted factors that induce differentiation, suppress proliferation, and inhibit angiogenesis. Two angiogenesis inhibitors, pigment epithelium-derived factor and tissue inhibitor of metalloproteinase-2, have been detected in Schwann cell secretions. Here, we isolated another Schwann cell-derived secreted inhibitor of angiogenesis, a 43-kDa protein identified as SPARC (secreted protein acidic and rich in cysteine), an extracellular matrix protein. We found SPARC to be critical for the antiangiogenic phenotype of cultured Schwann cells. We also show that purified SPARC potently inhibits angiogenesis and significantly impairs NB tumor growth in vivo. SPARC may be an effective candidate for the treatment of children with clinically aggressive, Schwannian stroma-poor NB tumors.

UR - http://www.scopus.com/inward/record.url?scp=0037115291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037115291&partnerID=8YFLogxK

M3 - Article

C2 - 12499280

AN - SCOPUS:0037115291

VL - 62

SP - 7357

EP - 7363

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 24

ER -